Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear

Inflammation Research

Volumn 45, Issue 7, 1996, Pages 316-323

  Inoue, H ^a   Nagata, N ^a   Koshihara, Y ^b  

^a Minophagen Pharmaceutical Co   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Ear oedema; Plasma extravasation; Tachykinin; Tachykinin receptor antagonist

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CHLORPHENIRAMINE; ENZYME INHIBITOR; HISTAMINE H1 RECEPTOR ANTAGONIST; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; NEUROKININ B; NOLPITANTIUM; OSANETANT; PHOSPHORAMIDON; PROTEINASE; SAREDUTANT; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EAR; EDEMA; EXTRAVASATION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN;

ANIMALS; CAPILLARY PERMEABILITY; EDEMA; GLYCOPEPTIDES; MALE; MICE; NEUROKININ A; NEUROKININ B; PIPERIDINES; QUINUCLIDINES; RECEPTORS, TACHYKININ; SUBSTANCE P;

EID: 0030055861     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02252943     Document Type: Article

References (49)

1. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-68.
2. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol 1985;114:61-6.
3. Fuller RW, Conradson T-B, Dixon CMS, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol 1987;92:781-8.
4. Guard S, Watson SP. Tachykinin receptor types: classification and membrane signaling mechanisms. Neurochem Int 1991;18:149-65.
5. Andrews PV, Helme RD, Thomas KL. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin. Br J Pharmacol 1989;97:1232-8.
6. O'Flynn NM, Helme RD, Watkins DJ, Burcher E. Autoradiographic localization of substance P binding sites in rat footpad skin. Neurosci Lett 1989;106:43-8.
7. Erjavec F, Lembeck F, Florjanc-Irman T, Skofitsch G, Donnerer J, Saria A, et al. Release of histamine by substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1981;317: 67-70.
8. Fewtrell CMS, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 1982;330: 393-411.
9. 1 receptor antagonists and the role of endogenous mediators. Br J Pharmacol 1995;114:1343-50.
10. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979;310:175-83.
11. Foreman JC, Jordan CC, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol 1983;335:449-65.
12. Iwamoto I, Yamazaki H, Tomioka H, Yoshida S. Inhibitory effect of tranilast on substance P-induced plasma extravasation in rat skin. Immunopharmacol Immunotoxicol 1991;13: 65-71.
13. Inoue H, Nagata N, Koshihara Y. Profile of capsaicin-induced mouse ear oedema as neurogenic inflammatory model: comparison with arachidonic acid-induced ear oedema. Br J Pharmacol 1993;110:1614-20.
14. Jacques L, Couture R, Drapeau G, Regoli D. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Arch Pharmacol 1989;340:170-9.
15. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel J-F, Blanchard J-C, Laduron PM. Pharacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 1991;88:10208-12.
16. Lembeck R, Donnerer J, Tsuchiya M, Nagahisa A. The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 1992;105:527-30.
17. 1 receptor antagonist. Eur J Pharmacol 1993;250:403-13.
18. Emonds-Alt X, Vilain P, Goulaouic P, Proietto V, Van Broeck D, Ȧdvenier C, et al. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci 1992;50:101-6.
19. 3 receptor. Life Sci 1995;56:27-32.
20. Cochran WG, Cox GM, editors. Experimental Designs. 2nd ed. New York: Wiley, 1957.
21. 1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically. Br J Pharmacol 1993;109:159-64.
22. 2 receptors mediate plasma extravasation in guinea-pig lower airways. Br J Pharmacol 1993;108:383-6.
23. 2 receptor antagonist. Eur J Pharmacol 1993;234:83-90.
24. Iwamoto I, Nadel JA. Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin. Life Sci 1989;44:1089-95.
25. Ralevic V, Khalil Z, Helme RD, Dusting GJ. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol 1995;284:231-9.
26. 1 receptors mediate tachykinin-induced increase in microvascular clearance in hamster cheek pouch. Am J Physiol 1993;265:H593-8.
27. Lam FY, Ferrell WR. Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br J Pharmacol 1991;103:1263-7.
28. 1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint. Agents Actions 1993;40:171-5.
29. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24,11. Biochem J 1984;223:433-40.
30. Sakurada T, Tan-no K, Yamada T, Sakurada S, Kisara K. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking, and scratching behaviour in mice. Pharmacol Biochem Behav 1990;37:779-83.
31. 1 receptor-mediated plasma extravasation in the rat trachea. Agents Actions 1994;42:34-9.
32. Johnson AR, Ashton J, Schulz WW, Erdös EG. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564-8.
33. Wang L, Sadoun E, Stephens RE, Ward PE. Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides 1994;15:497-503.
34. Suzuki H, Yoshioka K, Yanagisawa M, Urayama O, Kurihara T, Hosoki R, et al. Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord. Br J Pharmacol 1994;113:310-6.
35. Tsuchida K, Shigemoto R, Yokota Y, Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur J Biochem 1990;193:751-7.
36. Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 1987;139:749-54.
37. Hartung H-P, Wolters K, Toyka KV. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 1986;136:3856-63.
38. von Restorff B, Kemeny L, Michel G, Ruzicka T. Specific binding of substance P in normal human keratinocytes [abstract]. J Invest Dermatol 1992;98:510.
39. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229-308.
40. Rameshwar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 1993;15:2484-96.
41. Herzberg U, Murtaugh MP, Mullet MA, Beitz AJ. Electrical stimulation of the sciatic nerve alters neuropeptide content and lymphocyte migration in the subcutaneous tissue of the rat hind paw. Neuroreport 1995;6:1773-7.
42. Abelli L, Somma V, Maggi CA, Regoli D, Astolfi M, Parlani M, et al. Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors. J Auton Pharmacol 1989;9:253-63.
43. 1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 1995;268:L263-9.
44. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF. Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 1993;177:1269-76.
45. Kenins P, Hurley JV, Bell C. The role of substance P in the axon reflex in the rat. Br J Dermatol 1984;111:551-9.
46. Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987;40:109-17.
47. Mousli M, Bronner C, Bueb J-L, Tschirhart E, Gies J-P, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharm Exp Ther 1989;250:329-35.
48. Mousli M, Hugli TE, Landry Y, Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacol 1994;27:1-11.
49. Inoue H, Nagata N, Koshihara Y. Participation of serotinin in capsaicin-induced mouse ear edema. Jpn J Pharmacol 1995;69:61-8.